WHAT IS AN ADEQUATE
MARGIN DURING BCS?
 A surgeon’s view
                   Michel Daher, MD, FACS
                      President, Lebanese Cancer Society
            Professor of Surgery- University of Balamand
     Director, Ethics & Bioethics Teaching Program, UOB
                       Saint George Hospital- UMC, Beirut

              3rd EASO Breast Reconstructive Workshop
                                Cairo, March 28, 2011
Germany




U.K.




  Portugal



                       Antalya




                                     Jordan


                                 Saudi Arabia
Republic of Lebanon

 Population:
  4.225.000
 Area: 10.452
        Km2
 Specificity &
  Diversity:
  - Cultural
  - Spiritual
Breast Cancer Incidence (ASR)
Breast Cancer in ME countries(1)
 Currently, breast cancer incidence
  rates in ME are lower than in more
  developed countries (4-5X lower
  ASR than the U.S.)

 Screening is a challenge due to this
  lower incidence (yield) and more
  importantly, to inadequate
  infrastructure for screening and
  follow-up of what is found in a
  screening program.

 A demographic shift toward older
  populations is occurring that will
  result in many more breast cancers     U.S. ASR = 123.8
  in the future.
Breast Cancer in ME countries (2)
 Late stage at diagnosis is
  more common resulting in
  higher mortality to
  incidence ratios

 The contribution of biology
  to poor outcomes warrants
  more research.

 Palliative care services are
  grossly inadequate
  resulting in unnecessarily
  painful end-of –life and
  deaths .
Breast Cancer in ME countries (3)
            Incidence Rates
There are no accurate data about neighboring
  countries, but what is available shows that
  Lebanon has the highest rate in the Middle
  East.
     Egypt (El Gharbiah)    ASR: 49.6 (2002)
     Jordan                 ASR: 21.3 (1997)
     Algeria                ASR: 9.5 (1997)
     Kuwait                 ASR: 32.8 (1997)
     Tunisia                ASR: 16.7 (1994)
     Lebanon                ASR: 69.1 (2004)
Cancer in Lebanon
Annual New Cases* :
 2003-         7780 cases
 2004-         7450 cases
 2005-         8254 cases
 2006-         8230 cases
 2007-         8330 cases
 2008-         8250 cases
Death rate       6.39 per 1,000
Total deaths / year      24.092
- Cardio-V diseases      40%
- Cancers                13%
                            *Lebanese National Cancer Registry since 2003
Breast Cancer in Lebanon
 Most Common Cancer in women
  worldwide

 InLebanon: More than One-third of all
  women cancers are breast cancers
  (Around 1420 cases a year)

 In   most Arab Countries:
      More than 1/3 of all women cancers are
       Breast Cancer
      More than ½ of patients are below age 50
       years
Evolution In Surgical Techniques




 Better knowledge of Natural History

 Integration in Multidisciplinary Strategy

 Adoption of Screening Campaigns
Objectives of Surgery
        in Breast Cancer

 Confirm the Diagnosis ( most often
  known before surgery)
 Define Prognostic Factors
 Achieve Loco-regional Control
 Preserve or Reconstruct the Breast
Surgical options in Primary BC
 Modified
         radical Mastectomy +/-
 Reconstruction

 Modifiedradical Mastectomy with
 contralateral prophylactic Mastectomy

 Breast   Conservative Surgery
Options between Modified Radical and
          Conservative TT

   Local Control
   Survival
   Quality of Life
   Cosmetic Results
   Ppsychological Acceptance
   Follow up
   Cost
Factors that may influence surgical option for
            primary breast cancer

 Patient preference
 Pregnancy
 Multifocality (same quadrant)
 Response to Neo-Adjuvant Chemotherapy
 Tumor size in relation to breast size
 Retroareolar localisation
 Lobular Invasive Carcinoma
 Young Patient with Extensive Intraductal
  Carcinoma
Contra-indications for Conservative
           Treatment (1)

       Modified Radical Mastectomy is mandatory

Tumor Multicentricity
Malignant Diffuse Microcalcifications
Failure of Neo-Adjuvant Chemotherapy
Previous Thoracic Irradiation
Resection Margins Positive for Tumor
Contra-indications for Conservative
           Treatment (2)

       Modified Radical Mastectomy is Mandatory


Inflammatory Carcinoma
Locally Advanced Carcinoma (skin infiltration)
Associated Diseases excluding Radiotherapy
(Sclerodermia, Tuberculosis)
Non Compliance for Post operative Surveillance
Final Decision for Surgical Option for
         primary breast cancer

 Preop  and Postop Radiology Study and may
  include MRI
 Multidisciplinary concertation
 Optimal Surgery: Quality of Resection
  (margin control), Esthetic Result
  (Oncoplasty)
 Expertise of the Pathologist (Frozen Section,
  Margin Control…)
 Final Pathology
Breast conserving surgery

140



120



100



80



60



40



20



 0
      1955 1958 1960 1964 1967 1971 1973 1975 1977 1979 1981 1983 1985 1987 1989 1991 1993 1995 1997 1999 2001

-20                                                                                                  18
Conservative treatment of breast cancer


  1
                           +                       +/-
Breast conserving surg              Radiotherapy         Systemic treatment




  2                            +                            +
      Systemic treatment           Breast conserving surg       Radiotherapy


                                                   +
                                                         Systemic treatment
                                                                          19
Conservative Treatment of Breast Cancer


  Excision of the Tumor together with at least 2
  cm of tissue around the tumor + HP test of the
  tumor and of the specimen margins
   Quadrantectomy
     In case of intra-ductal (in situ) component
   Lumpectomy
     High risk of residual microscopic disease
     Frequent recurrence                           20
The « Must » of a Conservative Treatment



                     Acceptable Local Control (<1% recurrence/year)

                     Acceptable Cosmetic Result (Shape, Volume,
                     Sensibility, Symetry) of Breast

                     Acceptable Morbidity ( due to axillary dissection)

                     Acceptaple Psychological Result
Veronesi U.; Changing concepts in breast cancer management, The European Journal of Cancer, vol. 34, Pergamon, sept. 1998, pg.3;
Development Panel Consensus National Institute of Health Consensus Statement; Treatment of early-stage breast cancer. J. Natl. Cancer Just Monogr. 1992; 11: 11   ;
Different Clinical Situations
Non Palpable Lesions
- Increase in frequency/ Screening
- Preop Diagnosis by Micro or Macro Biopsies
- Preoperative Localisation ( # méthods )
- Radiology Confirmation of the Oriented Specimen


Palpable Tumors
- Preop Diagnosis by FNA or FNB
-Allow a one-stage Good and Complete Excision
      “The first excision is the best excision”
The Incisions
Depends of: the Localisation, Site, Size, Shape and
Breast Size

Different Types:
- Direct Incision:
- Peri-Areolar Incision:



                               Petit JY et al. Atlas of Breast Surgery (2008).

      These Incisions must take into consideration the
             possibility of a later mastectomy
Breast Excision/ Partial Mastectomy
-Quadrandectomy:




- Tumorectomy:
WHAT IS AN ADEQUATE MARGIN DURING
               BCS?

                Or what is a good
                surgical resection?
WHAT IS AN ADEQUATE MARGIN DURING
                 BCS?

 In all studies with careful case definition,
  the determination of clear margins has
  been the most important feature predicting
  the success of excision.
 However, overall size, some special
  histologic patterns, and focal density of
  disease near the margin have an effect in
  some studies.
WHAT IS AN ADEQUATE MARGIN DURING
                 BCS?

• Need for close collaboration between
  Surgeon, Pathologist, and Radiologist
• Specimen oriented, not opened, fresh,
  and Inked
• Distance in mm between Tumor and
  Margin
• Histology: Invasive or In Situ
Specimen Management
for the Pathologist
           Orientation
           Fresh
           Closed
           Inked
WHAT IS AN ADEQUATE MARGIN DURING
                 BCS?

 Definition of a Negative Margin
 Does Clear Margins= Complete Local
  Control of the Disease?
 Is there a correlation between
  Local Recurrence and Margins Status?
 Which type of Positive Margin Predict
  Residual Tumor?
 What size of Negative Margins we Need?
WHAT IS AN ADEQUATE MARGIN DURING
                 BCS?

 Definition  of a Negative Margin
 Does Clear Margins= Complete Local
  Control of the Disease?
 Is there a correlation between
  Local Recurrence and Margins Status?
 Which type of Positive Margin Predict
  Residual Tumor?
 What size of Negative Margins we Need?
Definition of a Negative Margin:
          controversies

•  Margin microscopically négative( NSABP)
 • 1mm
 • 5mm
 • 1cm
 • More than 1cm ( Milano) ( Silverstein)
“ What is clear from the
 preponderance of studies is that it is
 absolutely unacceptable to have
 tumor cells directly at the cut edge
 of the excised specimen”

    S. Eva Singletary, MD, The American
     Journal of Surgery, 2002
WHAT IS AN ADEQUATE MARGIN DURING
                 BCS?

 Definition of a Negative Margin
 Does Clear Margins= Complete Local
  Control of the Disease?
 Is there a correlation between
  Local Recurrence and Margins Status?
 Which type of Positive Margin Predict
  Residual Tumor?
 What size of Negative Margins we Need?
Does Clear Margins= Complete Local
      Control of the Disease?

  Review  of cases with residual tumor
   after Tumorectomy with Clear Margins *
      *13 - 25 % Residual Tumor


  And   after systematic wider reexcision**
      **Total: 34/177 19,2 %
Does Clear Margins= Complete Local
          Control of the Disease?
    Author (Year)   Nb with residual T (margin < 0)
   Smitt   (95)         2/8        25 %
   Beron   (96)         5/38       13 %
   Saarela (97)         4/26       15 %
   Beck    (98)         23/105     22 %
Peritumoral
microscopic disease


  17%
    42%
      59%
               1    1    1
          T1   cm   cm   cm




                              36
Does Clear Margins= Complete Local
      Control of the Disease?
   Clear Margins does not guarantee for a complete
    excision of the disease

   This can explain the Recurrence Rate at 10 years
    after quadrantectomy:
        Without RadioT        27,1 %
        With RadioT           6,9 %

   The risk for residual disease is minimal but not nil
    for clear margins

             What size of Neg Margins we need ?
WHAT IS AN ADEQUATE MARGIN DURING
                 BCS?

 Definitionof a Negative Margin
 Does Clear Margins= Complete Local
  Control of the Disease?
 Is there a correlation between
  Local Recurrence and Margins Status?
 Which type of Positive Margin Predict
  Residual Tumor?
 What size of Negative Margins we Need?
Is there a correlation between
 Local Recurrence and Margins Status?

 Negative  Margins:              2-12%
 “Close” Margins (less than1mm): 6-13%
 Focally Positive Margins:       ~14%
 Multiple Focally Pos Margins:   15-27%




                   J Am Coll Surg 2007;205: 362–376.
Is there a correlation between
Local Recurrence and Margins Status?
   Positive Margin does not mean obligatory
    résidual tumor*

   Local Recurrence increases if Positive Margins*
       8 - 25 % follow up 3,5 à 4,5 y (8-13-13-18-25)
       6 - 24 % follow up 5 - 8 y (6-10-10-10-11-15-16-17- 19-20-22-
        24)
       12 - 31 % follow up 10 y (12-15-16-31)

   Local Recurrence is earlier in positive margins
    with Invasive v/s In Situ**
       20 % at follow up 5 y
       29 % at follow up 10 y
     *(Horiguchi 99, Gage 96, Dibiase 98, Peterson 99)
     **(D Cowen, G Houvenaeghel, V Bardou et al IJROBP 2000)
WHAT IS AN ADEQUATE MARGIN DURING
                 BCS?

 Definition of a Negative Margin
 Does Clear Margins= Complete Local
  Control of the Disease?
 Is there a correlation between
  Local Recurrence and Margins Status?
 Which type of Positive Margin Predict
  Residual Tumor?
 What size of Negative Margins we Need?
Which type of Positive Margin Predict
               Residual Tumor?
Review of Residual Tumor in Reexcision Specimen

   Author (year) Nb cases + margin No residual T
 Haga       1995            7/23        30 %
 Beron      1996            29/41       71 %
 Wazer      1997            71/160      44 %
 Saarela    1997            5/8         62 %
 Beck       1998            16/39       41 %
 Papa       1999            67/115      58 %

   Résidual T.: 29 à 70 %   191 / 386   49,5 %
Which type of Positive Margin Predict
                 Residual Tumor?
   Author     (year)        + margin           margin < 0

   Wazer      1997          89/160 56 %        22/61 36 %


   Beron      1996          12/41   29 %              13 %

   Predictive Factors for residual T.:
       + margin and Nb of + margins
       Présence of extensive intraductal component (Wazer)
Van Nuys Prognostic Index in DCIS

Score            1                 2   3

Size      =< 15 mm >15-40 mm           >40 mm

Margins   >=10 mm 1-10 mm              <1 mm

Grade     Low Grade Low Grade          High Grade
          No nécrosis   Nécrosis       Nécrosis
Van Nuys Prognostic Index in DCIS

Final Score   Recurrence   Survival (8y)
 3-4             3,8%         93%
 5-7             11,1%        84%
 8-9             26,5%        61%
WHAT IS AN ADEQUATE MARGIN DURING
                 BCS?

 Definition of a Negative Margin
 Does Clear Margins= Complete Local
  Control of the Disease?
 Is there a correlation between
  Local Recurrence and Margins Status?
 Which type of Positive Margin Predict
  Residual Tumor?
 What size of Negative Margins we Need?
What size of Negative Margins we
                     Need?
     Local Recurrence with > 1 mm free Margin

   Author Nb marge >1   marge <1 marge +   Follow up

   Recht 134      3         11       22         5y

   Borger 723     2         6        16         5

   Park 486       7         7        19         8

                 2-7%     6-11%
What size of Negative Margins we
                          Need?

       Local Recurrence with > 2<2mm free Margin
    Author   Nb  margin >2mm margin
                                    mm Followup

   Dewar       663      6       14       10
   Kini        400      6       -        10
   Smitt       303      2       24       10
   Freedman    1262     7       14       10
   Wazer       494      4       14       12
What size of Negative Margins we Need?
   Local Recurrence with > 5 mm free Margin

Margins             +       0-2              2-5 > 5
Local Rec           17% 9%                   5% 0% p: 0,009




Factors for Local Rec.: age < 45,
                        marge < 2mm

       Neuschatz et al Cancer 2003 - 509 pts, follow up 10y
Local Recurrence and Adjuvant Chemotherapy


                margin -            margin + <1
Follow up       5y     10y          5y       10y

% LR
ChemoT          3      7            1        12
No ChemoT 5            7            11       16
(p = 0,02)
Margin + ou <1: after ChemoT most of Local Recurrences
appears between 5 and 10 y


             G. Freedman et al IJROBP 1999
Need for Reexcision- When ?

  Neg Margins : NO
 “Close” margins= (>= than 2mm): Optional
 Focally Pos Margins: Yes
 Pos Margins or Multiple Focally+ :YES
                                Positive Margin
Need for Reexcision- How?

 Use  same incision (rarely have to enlarge)
 Prior orientation allows select resection
 Resect 0.5- 1.0 cm tissue for entire new
  margin
 Orient new margin with stitch placed at
                                        Positive Margin
  new margin
 Meticulous hemostasis
Conclusions (1)
   Conservative treatment of breast cancer involves Team Work.
    The results depend on the team members expertise and
    competence.
   “The first excision is the best excision”
   Specimen oriented, not opened, fresh, and Inked
   Definition of a Negative Margin: controversies

   Clear margins has been the most important feature predicting
    the success of excision

   There is a correlation between Local Recurrence, Overall
    Survival and Margins Status
Conclusions (2)
 Risk factors associated with higher local recurrences:
  + margins, < 40y patients, no adjuvant RadioT
 Recommendation for Reexcision with acceptable
  cosmetic result or Mastectomy if + Margins or Close
  Margin (less than 2 mm)
   Discuss alternatives: Boost RadioT

   Good Information to the patient: local recurrence,
    survival, therapeutic alternatives

   Experience, Volume, and Multidisciplinarity approach
Not to See This..
But This..
Breast Cancer Awareness
  Campaigns Lebanon
Breast Cancer Awareness
Campaigns Lebanon 2010




             2010
UPDATES ON CANCER PAIN & PALLIATIVE
               CARE

    Middle East Medical Assembly (MEMA)

             In Collaboration with

      Lebanese Cancer Society (LCS)
   Rafic Hariri School of Nursing HSON)
Lebanese Society for the Study of Pain (LSSP)
              Friday May 6, 2011
               Beirut, Lebanon
             All Are Welcome

EASO2011 BRS 5 Daher

  • 1.
    WHAT IS ANADEQUATE MARGIN DURING BCS? A surgeon’s view Michel Daher, MD, FACS President, Lebanese Cancer Society Professor of Surgery- University of Balamand Director, Ethics & Bioethics Teaching Program, UOB Saint George Hospital- UMC, Beirut 3rd EASO Breast Reconstructive Workshop Cairo, March 28, 2011
  • 2.
    Germany U.K. Portugal Antalya Jordan Saudi Arabia
  • 3.
    Republic of Lebanon Population: 4.225.000  Area: 10.452 Km2  Specificity & Diversity: - Cultural - Spiritual
  • 4.
  • 5.
    Breast Cancer inME countries(1)  Currently, breast cancer incidence rates in ME are lower than in more developed countries (4-5X lower ASR than the U.S.)  Screening is a challenge due to this lower incidence (yield) and more importantly, to inadequate infrastructure for screening and follow-up of what is found in a screening program.  A demographic shift toward older populations is occurring that will result in many more breast cancers U.S. ASR = 123.8 in the future.
  • 6.
    Breast Cancer inME countries (2)  Late stage at diagnosis is more common resulting in higher mortality to incidence ratios  The contribution of biology to poor outcomes warrants more research.  Palliative care services are grossly inadequate resulting in unnecessarily painful end-of –life and deaths .
  • 7.
    Breast Cancer inME countries (3) Incidence Rates There are no accurate data about neighboring countries, but what is available shows that Lebanon has the highest rate in the Middle East. Egypt (El Gharbiah) ASR: 49.6 (2002) Jordan ASR: 21.3 (1997) Algeria ASR: 9.5 (1997) Kuwait ASR: 32.8 (1997) Tunisia ASR: 16.7 (1994) Lebanon ASR: 69.1 (2004)
  • 8.
    Cancer in Lebanon AnnualNew Cases* :  2003- 7780 cases  2004- 7450 cases  2005- 8254 cases  2006- 8230 cases  2007- 8330 cases  2008- 8250 cases Death rate 6.39 per 1,000 Total deaths / year 24.092 - Cardio-V diseases 40% - Cancers 13% *Lebanese National Cancer Registry since 2003
  • 9.
    Breast Cancer inLebanon  Most Common Cancer in women worldwide  InLebanon: More than One-third of all women cancers are breast cancers (Around 1420 cases a year)  In most Arab Countries:  More than 1/3 of all women cancers are Breast Cancer  More than ½ of patients are below age 50 years
  • 10.
    Evolution In SurgicalTechniques Better knowledge of Natural History Integration in Multidisciplinary Strategy Adoption of Screening Campaigns
  • 11.
    Objectives of Surgery in Breast Cancer  Confirm the Diagnosis ( most often known before surgery)  Define Prognostic Factors  Achieve Loco-regional Control  Preserve or Reconstruct the Breast
  • 12.
    Surgical options inPrimary BC  Modified radical Mastectomy +/- Reconstruction  Modifiedradical Mastectomy with contralateral prophylactic Mastectomy  Breast Conservative Surgery
  • 13.
    Options between ModifiedRadical and Conservative TT Local Control Survival Quality of Life Cosmetic Results Ppsychological Acceptance Follow up Cost
  • 14.
    Factors that mayinfluence surgical option for primary breast cancer  Patient preference  Pregnancy  Multifocality (same quadrant)  Response to Neo-Adjuvant Chemotherapy  Tumor size in relation to breast size  Retroareolar localisation  Lobular Invasive Carcinoma  Young Patient with Extensive Intraductal Carcinoma
  • 15.
    Contra-indications for Conservative Treatment (1) Modified Radical Mastectomy is mandatory Tumor Multicentricity Malignant Diffuse Microcalcifications Failure of Neo-Adjuvant Chemotherapy Previous Thoracic Irradiation Resection Margins Positive for Tumor
  • 16.
    Contra-indications for Conservative Treatment (2) Modified Radical Mastectomy is Mandatory Inflammatory Carcinoma Locally Advanced Carcinoma (skin infiltration) Associated Diseases excluding Radiotherapy (Sclerodermia, Tuberculosis) Non Compliance for Post operative Surveillance
  • 17.
    Final Decision forSurgical Option for primary breast cancer  Preop and Postop Radiology Study and may include MRI  Multidisciplinary concertation  Optimal Surgery: Quality of Resection (margin control), Esthetic Result (Oncoplasty)  Expertise of the Pathologist (Frozen Section, Margin Control…)  Final Pathology
  • 18.
    Breast conserving surgery 140 120 100 80 60 40 20 0 1955 1958 1960 1964 1967 1971 1973 1975 1977 1979 1981 1983 1985 1987 1989 1991 1993 1995 1997 1999 2001 -20 18
  • 19.
    Conservative treatment ofbreast cancer 1 + +/- Breast conserving surg Radiotherapy Systemic treatment 2 + + Systemic treatment Breast conserving surg Radiotherapy + Systemic treatment 19
  • 20.
    Conservative Treatment ofBreast Cancer Excision of the Tumor together with at least 2 cm of tissue around the tumor + HP test of the tumor and of the specimen margins Quadrantectomy In case of intra-ductal (in situ) component Lumpectomy High risk of residual microscopic disease Frequent recurrence 20
  • 21.
    The « Must» of a Conservative Treatment Acceptable Local Control (<1% recurrence/year) Acceptable Cosmetic Result (Shape, Volume, Sensibility, Symetry) of Breast Acceptable Morbidity ( due to axillary dissection) Acceptaple Psychological Result Veronesi U.; Changing concepts in breast cancer management, The European Journal of Cancer, vol. 34, Pergamon, sept. 1998, pg.3; Development Panel Consensus National Institute of Health Consensus Statement; Treatment of early-stage breast cancer. J. Natl. Cancer Just Monogr. 1992; 11: 11 ;
  • 22.
    Different Clinical Situations NonPalpable Lesions - Increase in frequency/ Screening - Preop Diagnosis by Micro or Macro Biopsies - Preoperative Localisation ( # méthods ) - Radiology Confirmation of the Oriented Specimen Palpable Tumors - Preop Diagnosis by FNA or FNB -Allow a one-stage Good and Complete Excision “The first excision is the best excision”
  • 23.
    The Incisions Depends of:the Localisation, Site, Size, Shape and Breast Size Different Types: - Direct Incision: - Peri-Areolar Incision: Petit JY et al. Atlas of Breast Surgery (2008). These Incisions must take into consideration the possibility of a later mastectomy
  • 24.
    Breast Excision/ PartialMastectomy -Quadrandectomy: - Tumorectomy:
  • 25.
    WHAT IS ANADEQUATE MARGIN DURING BCS? Or what is a good surgical resection?
  • 26.
    WHAT IS ANADEQUATE MARGIN DURING BCS?  In all studies with careful case definition, the determination of clear margins has been the most important feature predicting the success of excision.  However, overall size, some special histologic patterns, and focal density of disease near the margin have an effect in some studies.
  • 27.
    WHAT IS ANADEQUATE MARGIN DURING BCS? • Need for close collaboration between Surgeon, Pathologist, and Radiologist • Specimen oriented, not opened, fresh, and Inked • Distance in mm between Tumor and Margin • Histology: Invasive or In Situ
  • 28.
    Specimen Management for thePathologist Orientation Fresh Closed Inked
  • 29.
    WHAT IS ANADEQUATE MARGIN DURING BCS?  Definition of a Negative Margin  Does Clear Margins= Complete Local Control of the Disease?  Is there a correlation between Local Recurrence and Margins Status?  Which type of Positive Margin Predict Residual Tumor?  What size of Negative Margins we Need?
  • 30.
    WHAT IS ANADEQUATE MARGIN DURING BCS?  Definition of a Negative Margin  Does Clear Margins= Complete Local Control of the Disease?  Is there a correlation between Local Recurrence and Margins Status?  Which type of Positive Margin Predict Residual Tumor?  What size of Negative Margins we Need?
  • 31.
    Definition of aNegative Margin: controversies • Margin microscopically négative( NSABP)  • 1mm  • 5mm  • 1cm  • More than 1cm ( Milano) ( Silverstein)
  • 32.
    “ What isclear from the preponderance of studies is that it is absolutely unacceptable to have tumor cells directly at the cut edge of the excised specimen”  S. Eva Singletary, MD, The American Journal of Surgery, 2002
  • 33.
    WHAT IS ANADEQUATE MARGIN DURING BCS?  Definition of a Negative Margin  Does Clear Margins= Complete Local Control of the Disease?  Is there a correlation between Local Recurrence and Margins Status?  Which type of Positive Margin Predict Residual Tumor?  What size of Negative Margins we Need?
  • 34.
    Does Clear Margins=Complete Local Control of the Disease?  Review of cases with residual tumor after Tumorectomy with Clear Margins *  *13 - 25 % Residual Tumor  And after systematic wider reexcision**  **Total: 34/177 19,2 %
  • 35.
    Does Clear Margins=Complete Local Control of the Disease? Author (Year) Nb with residual T (margin < 0)  Smitt (95) 2/8 25 %  Beron (96) 5/38 13 %  Saarela (97) 4/26 15 %  Beck (98) 23/105 22 %
  • 36.
    Peritumoral microscopic disease 17% 42% 59% 1 1 1 T1 cm cm cm 36
  • 37.
    Does Clear Margins=Complete Local Control of the Disease?  Clear Margins does not guarantee for a complete excision of the disease  This can explain the Recurrence Rate at 10 years after quadrantectomy: Without RadioT 27,1 % With RadioT 6,9 %  The risk for residual disease is minimal but not nil for clear margins  What size of Neg Margins we need ?
  • 38.
    WHAT IS ANADEQUATE MARGIN DURING BCS?  Definitionof a Negative Margin  Does Clear Margins= Complete Local Control of the Disease?  Is there a correlation between Local Recurrence and Margins Status?  Which type of Positive Margin Predict Residual Tumor?  What size of Negative Margins we Need?
  • 39.
    Is there acorrelation between Local Recurrence and Margins Status?  Negative Margins: 2-12%  “Close” Margins (less than1mm): 6-13%  Focally Positive Margins: ~14%  Multiple Focally Pos Margins: 15-27% J Am Coll Surg 2007;205: 362–376.
  • 40.
    Is there acorrelation between Local Recurrence and Margins Status?  Positive Margin does not mean obligatory résidual tumor*  Local Recurrence increases if Positive Margins*  8 - 25 % follow up 3,5 à 4,5 y (8-13-13-18-25)  6 - 24 % follow up 5 - 8 y (6-10-10-10-11-15-16-17- 19-20-22- 24)  12 - 31 % follow up 10 y (12-15-16-31)  Local Recurrence is earlier in positive margins with Invasive v/s In Situ**  20 % at follow up 5 y  29 % at follow up 10 y *(Horiguchi 99, Gage 96, Dibiase 98, Peterson 99) **(D Cowen, G Houvenaeghel, V Bardou et al IJROBP 2000)
  • 41.
    WHAT IS ANADEQUATE MARGIN DURING BCS?  Definition of a Negative Margin  Does Clear Margins= Complete Local Control of the Disease?  Is there a correlation between Local Recurrence and Margins Status?  Which type of Positive Margin Predict Residual Tumor?  What size of Negative Margins we Need?
  • 42.
    Which type ofPositive Margin Predict Residual Tumor? Review of Residual Tumor in Reexcision Specimen  Author (year) Nb cases + margin No residual T  Haga 1995 7/23 30 %  Beron 1996 29/41 71 %  Wazer 1997 71/160 44 %  Saarela 1997 5/8 62 %  Beck 1998 16/39 41 %  Papa 1999 67/115 58 %  Résidual T.: 29 à 70 % 191 / 386 49,5 %
  • 43.
    Which type ofPositive Margin Predict Residual Tumor?  Author (year) + margin margin < 0  Wazer 1997 89/160 56 % 22/61 36 %  Beron 1996 12/41 29 % 13 %  Predictive Factors for residual T.:  + margin and Nb of + margins  Présence of extensive intraductal component (Wazer)
  • 44.
    Van Nuys PrognosticIndex in DCIS Score 1 2 3 Size =< 15 mm >15-40 mm >40 mm Margins >=10 mm 1-10 mm <1 mm Grade Low Grade Low Grade High Grade No nécrosis Nécrosis Nécrosis
  • 45.
    Van Nuys PrognosticIndex in DCIS Final Score Recurrence Survival (8y)  3-4 3,8% 93%  5-7 11,1% 84%  8-9 26,5% 61%
  • 46.
    WHAT IS ANADEQUATE MARGIN DURING BCS?  Definition of a Negative Margin  Does Clear Margins= Complete Local Control of the Disease?  Is there a correlation between Local Recurrence and Margins Status?  Which type of Positive Margin Predict Residual Tumor?  What size of Negative Margins we Need?
  • 47.
    What size ofNegative Margins we Need? Local Recurrence with > 1 mm free Margin  Author Nb marge >1 marge <1 marge + Follow up  Recht 134 3 11 22 5y  Borger 723 2 6 16 5  Park 486 7 7 19 8 2-7% 6-11%
  • 48.
    What size ofNegative Margins we Need?  Local Recurrence with > 2<2mm free Margin Author Nb margin >2mm margin mm Followup  Dewar 663 6 14 10  Kini 400 6 - 10  Smitt 303 2 24 10  Freedman 1262 7 14 10  Wazer 494 4 14 12
  • 49.
    What size ofNegative Margins we Need? Local Recurrence with > 5 mm free Margin Margins + 0-2 2-5 > 5 Local Rec 17% 9% 5% 0% p: 0,009 Factors for Local Rec.: age < 45, marge < 2mm Neuschatz et al Cancer 2003 - 509 pts, follow up 10y
  • 50.
    Local Recurrence andAdjuvant Chemotherapy margin - margin + <1 Follow up 5y 10y 5y 10y % LR ChemoT 3 7 1 12 No ChemoT 5 7 11 16 (p = 0,02) Margin + ou <1: after ChemoT most of Local Recurrences appears between 5 and 10 y G. Freedman et al IJROBP 1999
  • 51.
    Need for Reexcision-When ?  Neg Margins : NO  “Close” margins= (>= than 2mm): Optional  Focally Pos Margins: Yes  Pos Margins or Multiple Focally+ :YES Positive Margin
  • 52.
    Need for Reexcision-How?  Use same incision (rarely have to enlarge)  Prior orientation allows select resection  Resect 0.5- 1.0 cm tissue for entire new margin  Orient new margin with stitch placed at Positive Margin new margin  Meticulous hemostasis
  • 53.
    Conclusions (1)  Conservative treatment of breast cancer involves Team Work. The results depend on the team members expertise and competence.  “The first excision is the best excision”  Specimen oriented, not opened, fresh, and Inked  Definition of a Negative Margin: controversies  Clear margins has been the most important feature predicting the success of excision  There is a correlation between Local Recurrence, Overall Survival and Margins Status
  • 54.
    Conclusions (2)  Riskfactors associated with higher local recurrences: + margins, < 40y patients, no adjuvant RadioT  Recommendation for Reexcision with acceptable cosmetic result or Mastectomy if + Margins or Close Margin (less than 2 mm)  Discuss alternatives: Boost RadioT  Good Information to the patient: local recurrence, survival, therapeutic alternatives  Experience, Volume, and Multidisciplinarity approach
  • 55.
    Not to SeeThis..
  • 56.
  • 57.
    Breast Cancer Awareness Campaigns Lebanon
  • 58.
  • 60.
    UPDATES ON CANCERPAIN & PALLIATIVE CARE Middle East Medical Assembly (MEMA) In Collaboration with Lebanese Cancer Society (LCS) Rafic Hariri School of Nursing HSON) Lebanese Society for the Study of Pain (LSSP) Friday May 6, 2011 Beirut, Lebanon All Are Welcome